John Duncan Higgons Insider Trading $JNCE Jounce Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Duncan Higgons.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Duncan Higgons. John Duncan Higgons is Chief Operating Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Jounce Therapeutics, Inc. ($JNCE).
John Duncan Higgons in Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Duncan Higgons: Director
Holdings: 9,713 shares
Current Value: $168,035
Latest Transaction: Apr 16 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Duncan Higgons in Jounce Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 10.00 | 200 | 2,000 | 9,713 | 9.9 K to 9.7 K (-2.02 %) |
| Mar 17 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 12.80 | 200 | 2,560 | 9,913 | 10.1 K to 9.9 K (-1.98 %) |
| Feb 18 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 11.78 | 200 | 2,356 | 10,113 | 10.3 K to 10.1 K (-1.94 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 11.11 | 200 | 2,222 | 10,313 | 10.5 K to 10.3 K (-1.90 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 12.00 | 1,500 | 18,000 | 10,513 | 12 K to 10.5 K (-12.49 %) |
| Jun 29 2020 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Option Exercise | A | 7.58 | 13,550 | 102,709 | 13,550 | |
| Jan 08 2020 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 8.11 | 1,500 | 12,165 | 12,013 | 13.5 K to 12 K (-11.10 %) |
| Jun 13 2019 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Option Exercise | A | 4.46 | 15,700 | 70,022 | 15,700 | |
| Jun 21 2018 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Option Exercise | A | 7.92 | 13,550 | 107,316 | 13,550 | |
| Feb 02 2017 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Buy | P | 16.00 | 6,700 | 107,200 | 27,025 | 20.3 K to 27 K (+32.96 %) |
Page: 1